We are currently seeking nominations for this award -
please see below
Background Information
The Research Paper of the Year Award is now in
its fifteenth year. Its purpose is to:
- Raise the profile of research in general
practice and primary care.
- Demonstrate that high quality research is being undertaken in
general practice and primary care.
- Give recognition to a group of researchers or an individual
researcher, who have/has undertaken
and
published an exceptional piece of research
relating to general practice or primary care.
- Recognise the increasing importance of a multi-disciplinary
approach to primary care.
This year, the award will
also include additional specific categories aligned to the six NIHR
topic specific research networks of diabetes; mental health;
stroke; dementias and neurodegenerative diseases; cancer; medicines
for children as well as primary care.
Each sub-category winner(s)
will receive a prize. An additional award will be awarded to the
overall winning paper, selected from the sub-category winners. The
authors of the overall winning paper will also be invited to
present at the annual RCGP and Society for Academic Primary Care
conference.
The sub-category winners
will be announced in early Summer 2012 with the Research Paper of
the Year overall winner announced at the awards ceremony, supported
by Novartis, in June 2012.
The Research Paper of the Year Award is supported by an
unconditional grant from Novartis Pharmaceuticals UK
Ltd
How to Nominate/Apply:
Please send an electronic copy of the paper or a link to it
to circ@rcgp.org.uk or post
to:
Clinical Innovation and Research Centre
Royal College of General Practitioners
1 Bow Churchyard
London EC4M 9DQ
A paper can be nominated by its author(s) or a person with no
connection to the paper. Please call us on 0203 188 7597 if you
have any queries.
The deadline for nominations for the 2011 Research
Paper of the Year Award is now closed.
Conditions of Entry
Criteria for the Award
The Award Panel is
especially keen to receive nominations from people who have a read
a paper whose content has particularly impressed them, for example,
because of the applicability of its findings to service general
practice or because the paper relates to a major issue affecting
general practice and/or primary care.
The panel of judges for this award apply
the following criteria when they are reviewing entries for this
award:
Originality
Originality is a major
criterion. The panel looks at whether papers are the extension of a
previously existing idea or of previous work or for example, a
duplication of study that has already been done but in a different
setting. It will consider whether a paper constitutes a study of a
subject which has not been previously researched or a subject that
has not be satisfactorily studied in the past.
Applicability
Papers submitted for this
award are expected to contribute clearly to the body of medical
science and to have applicability to working general practitioners
in the United Kingdom and/or the Republic of Ireland. Merit will be
given to those studies that have direct relevance to and can be
easily implemented within a service practice setting. The panel
considers whether the paper in some way illuminates general
practitioners' understanding of disease, service delivery or the
kind of patients that consult GPs. The panel will also assess
whether the content of a paper will be of obvious help or
assistance to service GPs.
Standing of General Practice/Primary
Care
The panel considers how the paper contributes to
the standing of general practice and primary care within the
academic community of medicine as a whole.
Presentation
The panel considers the presentation, clarity and
style of papers as well as their scientific soundness and
value.
Authors
Additional credit will be given, as part of the
assessment to papers that are multi-disciplinary in their
authorship.
GP contribution
The lead researcher for
studies relating to general practice and primary care is not always
a GP. Credit will be given where a general practitioner is the
principal investigator. For entries to be eligible, at least one of
the paper's authors should have been a general practitioner
normally undertaking some clinical sessions within the United
Kingdom or the Republic of Ireland at the time the study was
undertaken. If this was not the case, entries for this award may be
accepted at the discretion of the Chair of the panel of assessors,
dependent on the reason for the break in the relevant author's
service or other pertinent background information.
Topic
Papers should preferably
relate to clinical work with patients in the general practice or
primary care setting and the project must have been undertaken
within the UK and/or the Republic of Ireland. There is no specific
topic on which papers are being sought. Papers relating to
philosophical aspects of general practice and primary care and meta
analyses are eligible but, in the case of two papers attracting
equal scores, additional weight is likely to be allocated to a
paper based on primary research.
Papers could, for example, cover one or more of
the following aspects:
Research in which the prevention of complications
is clearly demonstrated
2010 RCGP and Novartis Research Paper of the Year award -
List of Nominated Papers - please click on the link on the
left
2010 Winning Paper
The 2010 RCGP Research Paper of the Year award
was given to the paper: Survival and cessation in
injecting drug users: prospective observational study of outcomes
and effect of opiate substitution treatment"
by
Jo Kimber, Lorraine
Copeland, Matthew Hickman, John Macleod, James McKenzie, Daniela De
Angelis, James Roy Robertson
Over thirty years, ago a practice
serving an economically deprived population was faced with the
challenge of rapid HIV spread amongst its drug injecting patients.
In addition to providing the best clinical care they could, the
Muirhouse Medical Group created the Edinburgh addiction cohort
which recruited 794 people from 1980-2007.
Over the years this internationally important study has reported on
many aspects of the problems faced by patients, their care
providers and the community. for continuing to provide valuable new
insights 31 years after the study began. In the continuing debate
about how clinicians and policymakers should respond to injecting
drug use this study provides clear evidence to inform that
debate.
They formed links with local NHS services, excellent research teams
in Bristol, Cambridge, London and the Information and Statistics
Division Scotland. The importance of their work has been recognised
by a range of funding bodies over the years particularly the
Scottish Chief Scientist Office and the National Institute for
Health Research. Remarkably for such a difficult to study
population, they were able to study the records of 655 (82%) of the
patients in the cohort including 187 of those who died. The team
also interviewed 432 patients to obtain the rich data presented in
the paper.
circ@rcgp.org.uk
020 3188 7597